Three Cases of Anaphylactoid Reaction to Haemaccel

Haemaccel Data Sheet. Hoechst Australia Ltd, 1988.

Davies M.J. Polygeline. Develop Biol Standard 1987; 67: 129–131.

Ring J. , Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 26: 466–469.

Freeman M.K. Fatal reaction to Haemaccel. Anaesthesia 1979; 34: 341–343.

Barrett S. , Purcell G.J. Refractory bronchospasm following Haemaccel infusion and bupivacaine epidural anaesthesia. Anaesth Intens Care 1988; 16: 208–211.

Lund N. Anaphylactic reaction induced by infusion of Haemaccel. Br J Anaesth 1973; 45: 929.

Wisborg K. Anaphylactic reactions induced by infusion of polygeline (Haemaccel). Br J Anaesth 1975; 47: 1116–1117.

Isbister J.P. , Fisher M.M. Adverse effects of plasma volume expanders. Anaesth Intens Care 1980; 8: 145–151.

Ring J. Anaphylactoid reactions to plasma substitutes. Int Anaesthesiol Clin 1985; 23: 67–95.

Adelmann-Grill B. , Schoning B. Lack of evidence for immunological reactions to polygelatin. Develop Biol Standard 1980; 48: 235–240.

Lorenz W. , Doenicke A. , Schoning B. , Karges H. , Schmal A. Incidence and mechanisms of adverse reactions to polypeptides in man and dog. Develop Biol Standard 1980; 48: 207–234.

Weis K.H. Haemaccel 35: Nebenreaktionen in einer multizentrischen, prospektiven studie. Anaesthetist 1983; 32: 488–493.

Vervloet D. , Senft M. , Dugue P. , Arnaud A. , Charpin J. Anaphylactic reactions to modified fluid gelatins. J Allergy Clin Immunol 1983; 71: 535–540.

Fisher M. Intradermal testing after anaphylactoid reactions to anaesthetic drugs: Practical aspects of performance and interpretation. Anaesth Intens Care 1984; 12: 115–120.

Schoning B. , Lorenz W. , Doenicke A. Prophylaxis of anaphylactoid reactions to a polypeptidal plasma substitute by H1 — plus H2 — recepter antagonists: Synopsis of three randomised controlled trials. Klin Wochenschr 1982; 60: 1048–1055.

Schoning B. , Lorenz W. Prevention of allergoid (cutaneous anaphylactoid) reactions to polygeline (Haemaccel) in orthopaedic patients by premedication with H1 — and H2 — receptor antagonists. Develop Biol Standard 1980; 48: 241–249.

Australian Adverse Drug Reactions Bulletin. March 1989.